RITONAVIR INHIBITS PRASUGREL IN VITRO BIOACTIVATION: A POTENTIAL PHARMACOKINETIC INTERACTION

被引：0
|
作者：
Ancrenaz, V
Daali, Y.
Samer, C.
Bosilkovska, M.
Dayer, P.
Desmeules, J.
机构：
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [31] Physiologically-based pharmacokinetic modeling predicts the drug interaction potential of GLS4 in co-administered with ritonavir
    Sun, Zexu
    Zhao, Nan
    Xie, Ran
    Jia, Bo
    Xu, Junyu
    Luo, Lin
    Zhuang, Yulei
    Peng, Yuyu
    Liu, Xinchang
    Zhang, Yingjun
    Zhao, Xia
    Liu, Zhaoqian
    Cui, Yimin
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (09): : 1503 - 1512
  • [32] Atazanavir and lopinavir with ritonavir alone or in combination: analysis of pharmacokinetic interaction and predictors of drug exposure
    Di Giambenedetto, S.
    De Luca, A.
    Villani, P.
    Bacarelli, A.
    Ragazzoni, E.
    Regazzi, M.
    Cauda, R.
    Navarra, P.
    HIV MEDICINE, 2008, 9 (04) : 239 - 245
  • [33] Assessment of the Pharmacokinetic Interaction between Eltrombopag and Lopinavir-Ritonavir in Healthy Adult Subjects
    Wire, Mary B.
    McLean, Heidi B.
    Pendry, Carolyn
    Theodore, Dickens
    Park, Jung W.
    Peng, Bin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 2846 - 2851
  • [34] Lack of a pharmacokinetic interaction between escitalopram and the CYP3A4 inhibitor ritonavir
    Gutierrez, M
    Abramowitz, W
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 51S - 51S
  • [35] Pharmacokinetic Interaction Study of Ritonavir-Boosted Saquinavir in Combination with Rifabutin in Healthy Subjects
    Zhang, Xiaoping
    Fettner, Scott
    Zwanziger, Elke
    Rowell, Lucy
    Salgo, Miklos
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (02) : 680 - 687
  • [36] Pharmacokinetic Interaction between Indinavir and Darunavir with Low-Dose Ritonavir in Healthy Volunteers
    Sekar, Vanitha
    Lefebvre, Eric
    De Marez, Tine
    De Pauw, Martine
    De Paepe, Els
    Vangeneugden, Tony
    Hoetelmans, Richard M. W.
    INTERVIROLOGY, 2010, 53 (03) : 176 - 182
  • [37] Verification of a physiologically based pharmacokinetic model of ritonavir to estimate drug-drug interaction potential of CYP3A4 substrates
    Umehara, Ken-ichi
    Huth, Felix
    Won, Christina S.
    Heimbach, Tycho
    He, Handan
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (03) : 152 - 163
  • [38] Potential hazard of pharmacokinetic interactions between lopinavir-ritonavir protease inhibitors and irinotecan
    Corona, G
    Vaccher, E
    Cattarossi, G
    Sartor, I
    Toffoli, G
    AIDS, 2005, 19 (17) : 2043 - 2044
  • [39] EVALUATION OF THE POTENTIAL PHARMACOKINETIC INTERACTION OF LITHIUM AND ALPRAZOLAM
    EVANS, RL
    NELSON, MV
    MELETHIL, SK
    HORNSTRA, RK
    TOWNSEND, R
    SMITH, RB
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (06): : 457 - 458
  • [40] POTENTIAL PHARMACOKINETIC INTERACTION BETWEEN FELBAMATE AND PHENOBARBITAL
    GIDAL, BE
    ZUPANC, ML
    ANNALS OF PHARMACOTHERAPY, 1994, 28 (04) : 455 - 458
12345